Dr. Mukkamala is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2070 W Rudasill Rd
Ste 130
Tucson, AZ 85704Phone+1 520-797-4468Fax+1 520-797-4502
Education & Training
Ochsner Clinic FoundationFellowship, Hematology and Medical Oncology, 2018 - 2021
St Luke's University Hospital/Easton HospitalResidency, Internal Medicine, 2015 - 2018- Kasturba Med College MangaloreClass of 2003
Certifications & Licensure
AZ State Medical License 2021 - 2025
LA State Medical License 2018 - 2022
PA State Medical License 2015 - 2018- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- The Jacob Kincov Memorial Award 2018
- The Sanjiv Mangi Award 2017
- The John Updegrove Prize 2017
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsChallenging the conventional treatment of colon cancer by sentinel lymph node mapping and its role of detecting micrometastases for adjuvant chemotherapySukamal Saha, Mohamed H. Elgamal, Meghan Cherry, Robin Buttar, Swetha Pentapati
Clinical & Experimental Metastasis. 2018-08-01 - 12 citationsFerroxitosis: A cell death from modulation of oxidative phosphorylation and PKM2-dependent glycolysis in melanomaAlexander J. Lakhter, James Hamilton, Pierre C. Dagher, Suresh Mukkamala, Takashi Hato
Oncotarget. 2014-12-30 - 6 citationsA rare case of apical hypertrophic cardiomyopathy (AHCM).Seyed Abbas Mirabbasi, Koroush Khalighi, Suresh Mukkamala, Archana Kodali
Journal of Community Hospital Internal Medicine Perspectives. 2017-06-06
Abstracts/Posters
- CLO21-028: Clinical Outcomes for Advanced Hepatocellular Carcinoma Patients Treated With Systemic Agents in Real-World PracticeKarine Tawagi MD, Diana Maslov MD, Madhav KC MPH, Danny Markabawi MD, Suresh Mukkamala MD, Fady Farag MD, Helen Yuan MD, Adi Bamnolker DO, Rula Saeed MS, Zoe Blake BA,..., JNCCN, 3/17/2021
- PD-1/PD-L1/CTLA-4 INHIBITOR THERAPY FOLLOWING PROGRESSION ON A DIFFERENT PD-1/PD-L1 INHIBITOR: A CASE SERIESSuresh Mukkamala, Karine Tawagi, Marc Matrana, Journal for ImmunoTherapy of Cancer 2020, 11/9/2020
Professional Memberships
- Member
- Member
- Society for Immunotherapy of CancerMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
